RECRUITING

StrokeNet Thrombectomy Endovascular Platform

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

Official Title

STEP: StrokeNet Thrombectomy Endovascular Platform

Quick Facts

Study Start:2025-01-31
Study Completion:2030-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06289985

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Suspected diagnosis acute ischemic stroke
  2. 2. Likely causative intracranial large or medium vessel occlusion
  1. 1. Proven contraindication to endovascular thrombectomy
  2. 2. Prisoners/incarcerated

Contacts and Locations

Study Contact

Harriet Howlett-Smith, RN, CCRC
CONTACT
470-545-1190
Howletha@ucmail.uc.edu
Melissa Hoffman
CONTACT
513-558-2429
hoffm2ma@ucmail.uc.edu

Principal Investigator

Jordan J Elm, PhD
PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Eva A Mistry, MBBS, MSCI
PRINCIPAL_INVESTIGATOR
University of Cincinnati
Pooja Khatri, MD
PRINCIPAL_INVESTIGATOR
University of Cincinnati
Colin P Derdeyn, MD
PRINCIPAL_INVESTIGATOR
University of Virginia
Jeffery L Saver, MD
PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Tudor G Jovin, MD
PRINCIPAL_INVESTIGATOR
The Cooper Health System
Raul G Nogueira, MD, FAHA
PRINCIPAL_INVESTIGATOR
University of Pittsburgh
David Fiorella, MD, PhD
PRINCIPAL_INVESTIGATOR
Stony Brook University
Adnan Siddiqui, MD, PhD
PRINCIPAL_INVESTIGATOR
University at Buffalo
J Mocco, MD, MS
PRINCIPAL_INVESTIGATOR
MOUNT SINAI HOSPITAL

Study Locations (Sites)

Boston Medical Center
Boston, Massachusetts, 02118
United States
Stony Brook University Hospital
Stony Brook, New York, 11794
United States

Collaborators and Investigators

Sponsor: Medical University of South Carolina

  • Jordan J Elm, PhD, PRINCIPAL_INVESTIGATOR, Medical University of South Carolina
  • Eva A Mistry, MBBS, MSCI, PRINCIPAL_INVESTIGATOR, University of Cincinnati
  • Pooja Khatri, MD, PRINCIPAL_INVESTIGATOR, University of Cincinnati
  • Colin P Derdeyn, MD, PRINCIPAL_INVESTIGATOR, University of Virginia
  • Jeffery L Saver, MD, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles
  • Tudor G Jovin, MD, PRINCIPAL_INVESTIGATOR, The Cooper Health System
  • Raul G Nogueira, MD, FAHA, PRINCIPAL_INVESTIGATOR, University of Pittsburgh
  • David Fiorella, MD, PhD, PRINCIPAL_INVESTIGATOR, Stony Brook University
  • Adnan Siddiqui, MD, PhD, PRINCIPAL_INVESTIGATOR, University at Buffalo
  • J Mocco, MD, MS, PRINCIPAL_INVESTIGATOR, MOUNT SINAI HOSPITAL

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-31
Study Completion Date2030-01-31

Study Record Updates

Study Start Date2025-01-31
Study Completion Date2030-01-31

Terms related to this study

Additional Relevant MeSH Terms

  • Ischemic Stroke